Cardioprotective drugs and heart failure/cardiomyopathy incidence in chemotherapy-treated cancer survivors of breast cancer and non-Hodgkin lymphoma: a retrospective cohort study in England.
Saved in:
| Title: | Cardioprotective drugs and heart failure/cardiomyopathy incidence in chemotherapy-treated cancer survivors of breast cancer and non-Hodgkin lymphoma: a retrospective cohort study in England. |
|---|---|
| Authors: | Hindocha P; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1A 7HT, UK., Lyon AR; National Heart and Lung Institute, Imperial College London and Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK., Bhaskaran K; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1A 7HT, UK., Strongman H; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1A 7HT, UK. |
| Source: | European heart journal open [Eur Heart J Open] 2025 Apr 25; Vol. 5 (3), pp. oeaf039. Date of Electronic Publication: 2025 Apr 25 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Published by Oxford University Press on behalf of the European Society of Cardiology Country of Publication: England NLM ID: 9918282081406676 Publication Model: eCollection Cited Medium: Internet ISSN: 2752-4191 (Electronic) Linking ISSN: 27524191 NLM ISO Abbreviation: Eur Heart J Open Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
